Aladdin Healthcare Technologies SE announced the signing of a partnership with the Norweigan Centre of Healthy Ageing (NO-Age). NO-Age and Aladdin have agreed to collaborate, innovate and transform the future of digital healthcare, bringing positive health outcomes to people who have ageing related chronic diseases, such as Alzheimer's disease (AD), cardiovascular diseases, and diabetes. The parties intend to focus on the following 3 specific areas, which will enable the development of a superior AI diagnosis toolkit for early disease detection, clinical trials and Research and Development for key compounds, with a view to new drug and treatment discovery. The partnership brings together a combination of world-class doctors, scientists, AI engineers from leading medical and research institutes. Both parties view the partnership as a fundamental forward step to achieve the end goal of accelerating medical research and transforming patient care.